Dose dense Dreifach*Melphalan100 for multiple myeloma.

被引：0
|
作者：
Berz, David
McCormack, Elise M.
Winer, Eric S.
Karwan, Patricia
Colvin, Gerald
Rathore, Ritesh
Lum, Larry
Abedi, Mehrdad
Elfenbein, Gerald
Quesenberry, Peter J.
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Roger Williams Med Ctr, Providence, RI USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5465.5465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5465
引用
收藏
页码：462B / 462B
页数：1
相关论文
共 50 条
  • [1] Dose dense dreifach* melphalan 100 for multiple myeloma
    Berz, D.
    McCormack, E.
    Winer, E.
    Karwan, P.
    Colvin, G.
    Rathore, R.
    Lany, L.
    Elfenbein, G.
    Quesenberry, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 36 - 36
  • [2] An analysis of the pharmacokinetics of high dose intravenous Melphalan in multiple myeloma.
    Kalakonda, N
    Welby-Everard, P
    Dougal, M
    Ranson, M
    Scarffe, JH
    Chopra, R
    BLOOD, 1999, 94 (10) : 321B - 321B
  • [3] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A
  • [4] Effect of Obesity and Renal Insufficiency On Toxicity of High-Dose Melphalan for Multiple Myeloma.
    Vogl, Dan T.
    Paul, Thomas M.
    Stoopler, Eric
    Salazar, Gentian
    Davis, Lisa
    Kapoor, Shiv
    Zemel, Babette
    Yudkoff, Mark
    Jackson, Gail
    Basel-Brown, Lisa
    Rockwell, Kenneth
    Daikhin, Evgueni
    Swider, Cezary R.
    Washington, John
    Raguza-Lopez, Maria
    Tenhave, Thomas
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 483 - 484
  • [5] Comparison of high dose melphalan and a more intensive regimen of thiotepa, busulfan and cyclophosphamide in multiple myeloma.
    Anagnostopoulos, A
    Aleman, A
    Ayers, D
    Williams, P
    Xin, L
    Donato, M
    Alexanian, R
    Champlin, R
    Giralt, S
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [6] High dose melphalan followed by busulphan-cyclofosfamide and stem cell rescue in multiple myeloma.
    Huijgens, PC
    Ossenkoppele, GJ
    Jonkhoff, AR
    Legdeur, MCJC
    Zweegman, S
    Gloudemans, IJM
    BLOOD, 1996, 88 (10) : 3860 - 3860
  • [7] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
    Nowrousian, MR
    Wrzeciono, T
    Tewes, M
    Fossa, A
    Welt, A
    Schuett, P
    Brandhorst, D
    Kloke, O
    Schuette, J
    Seeber, S
    BLOOD, 2000, 96 (11) : 421A - 421A
  • [8] Feasibility of high dose busulfan and melphalan with autologous hematopoietic stem cell transplantation in multiple myeloma.
    Begum, U
    Fitzgerald, D
    Yong, LO
    Grand, M
    Thomas, U
    Chen, Y
    Patel, A
    Goodman, D
    Dillon, C
    Amorosi, E
    Cook, P
    BLOOD, 1997, 90 (10) : 4346 - 4346
  • [9] Busulphan and melphalan: A novel autograft conditioning regime in multiple myeloma.
    Clark, A
    Mitchell, L
    Alcorn, M
    Tansey, P
    Cook, G
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 100 - 100
  • [10] Thalidomide plus melphalan in relapsed-refractory multiple myeloma.
    Offidani, M
    Mele, A
    Marconi, M
    Corvatta, L
    Candela, M
    Pieroni, S
    Malerba, L
    Rupoli, S
    Olivieri, A
    Leoni, P
    BLOOD, 2001, 98 (11) : 311B - 311B
12345